Form 8-K - Current report:
SEC Accession No. 0001171843-25-003962
Filing Date
2025-06-18
Accepted
2025-06-18 16:21:10
Documents
12
Period of Report
2025-06-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_061825.htm   iXBRL 8-K 18779
  Complete submission text file 0001171843-25-003962.txt   181232

Data Files

Seq Description Document Type Size
2 XBRL LABEL FILE aptosecom-20250616_lab.xml EX-101.LAB 34239
3 XBRL PRESENTATION FILE aptosecom-20250616_pre.xml EX-101.PRE 22359
4 XBRL SCHEMA FILE aptosecom-20250616.xsd EX-101.SCH 3023
14 EXTRACTED XBRL INSTANCE DOCUMENT f8k_061825_htm.xml XML 3602
Mailing Address 66 WELLINGTON STREET WEST, SUITE 5300 TD BANK TOWER BOX 48 TORONTO A6 M5K 1E6
Business Address 66 WELLINGTON STREET WEST, SUITE 5300 TD BANK TOWER BOX 48 TORONTO A6 M5K 1E6 310-849-8060
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32001 | Film No.: 251057233
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)